What is AbCellera Biologics Inc.'s capex?

AbCellera Biologics Inc. (ABCL) reported capex of $3.83M in Q1 2026.

How has AbCellera Biologics Inc.'s capex changed year-over-year?

AbCellera Biologics Inc.'s capex decreased by 64.0% year-over-year, from $10.64M to $3.83M.

What is the long-term trend for AbCellera Biologics Inc.'s capex?

Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s capex has grown at a -7.5% compound annual growth rate (CAGR), from $58.45M to $42.77M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

AbCellera Biologics Inc. ABCL CapEx

CapEx at other companies

Twist Bioscience CorporationTWST

$7.89M+90.3%

Recursion Pharmaceuticals, Inc.RXRX

$258K-85.9%

AnaptysBio, Inc.ANAB

$17K-51.4%

ZymeworksZYME

$216K+1,250%

PrecigenPGEN

$258K-58.5%

ADMA BiologicsADMA

$2.54M-45.9%

Other financials

Income statement

See full

Revenue$8.3M+96.3%

Operating income-$57.5M+8.2%

Net income-$43.2M+5.4%

EPS (diluted)-$0.14+6.7%

Balance sheet

See full

Cash & equivalents$102.1M-44.6%

Total debt$140.2M+107%

Total equity$938.1M-8.3%

Total assets$1.3B-2.8%

Cash flow

See full

Operating cash flow-$33.5M-190%

Free cash flow-$37.4M-68.3%

Valuation

See full

Market cap$1.72B+59.2%

Enterprise value$1.76B+100.0%

P/S21.7×-25.0×

Profitability

See full

Operating margin-267.6%-120pp

Net margin-181.7%-77.9pp

FCF margin-238.9%-90.9pp

Returns & leverage

See full

Return on equity-14.7%-0.8pp

Debt / equity0.1×+0.1×

Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AbCellera Biologics Inc.'s capex?: AbCellera Biologics Inc. (ABCL) reported capex of $3.83M in Q1 2026.
How has AbCellera Biologics Inc.'s capex changed year-over-year?: AbCellera Biologics Inc.'s capex decreased by 64.0% year-over-year, from $10.64M to $3.83M.
What is the long-term trend for AbCellera Biologics Inc.'s capex?: Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s capex has grown at a -7.5% compound annual growth rate (CAGR), from $58.45M to $42.77M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.